A short protocol using dexamethasone and monophosphoryl lipid A generates tolerogenic dendritic cells that display a potent migratory capacity to lymphoid chemokines

BACKGROUND: Generation of tolerogenic dendritic cells (TolDCs) for therapy is challenging due to its implications for the design of protocols suitable for clinical applications, which means not only using safe products, but also working at defining specific biomarkers for TolDCs identification, deve...

Descripción completa

Detalles Bibliográficos
Autores principales: García-González, Paulina, Morales, Rodrigo, Hoyos, Lorena, Maggi, Jaxaira, Campos, Javier, Pesce, Bárbara, Gárate, David, Larrondo, Milton, González, Rodrigo, Soto, Lilian, Ramos, Verónica, Tobar, Pía, Molina, María Carmen, Pino-Lagos, Karina, Catalán, Diego, Aguillón, Juan Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674980/
https://www.ncbi.nlm.nih.gov/pubmed/23706017
http://dx.doi.org/10.1186/1479-5876-11-128

Ejemplares similares

Ejemplares similares